ArticleJournal for immunotherapy of cancer2021

T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia.

Sayed Shahabuddin Hoseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.